Industry News
Lifestyle And Environmental Factors Associated With Cancer Risk
Dec 25, 2011
It has been well established that certain lifestyle habits relate to the risk of certain cancers (e.g., smoking and lung cancer). In a well-done analysis, the authors estimate the proportion of cancer in the population associated with a variety of lifestyle and environmental factors. They find that smoking has, by far, the largest effect on the risk of cancer, with 19... Read More
Roche's Avastin Receives EU Approval For Ovarian Cancer
Dec 25, 2011
Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D... Read More
Researchers Present Findings From Kentucky Breast Cancer Patients With Disease Relapse
Dec 24, 2011
The University of Kentucky Markey Cancer Center breast oncologist Dr. Suleiman Massarweh and his research team presented findings from their studies on relapse of breast cancer at the San Antonio Breast Cancer Symposium this month. The two studies aimed to characterize further risk factors for presentation with metastatic disease or risk of early metastatic relapse after initial therapy... Read More
HPV Vaccine Does Not Alter Sexual Behavior
Dec 24, 2011
According to a national study by The Centers for Disease Control & Prevention published in the American Journal of Preventive Medicine, contrary to some people's belief, young women receiving recommended vaccinations for the prevention of human papillomavirus (HPV) infection and related cancers do not engage in more sexually risky behavior. Nicole C. Liddon, Ph.D... Read More
A New Sensor To Detect Lung Cancer From Exhaled Breath
Dec 24, 2011
Tecnalia, through the Interreg project Medisen, is contributing to develop biosensors capable of detecting the presence of tumour markers of lung cancer in exhaled breath... Read More
Drugs Used To Overcome Cancer May Also Combat Antibiotic Resistance
Dec 24, 2011
Drugs used to overcome cancer may also combat antibiotic resistance, finds a new study led by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University... Read More
Acid Reflux 50% More Common Than Ten Years Ago
Dec 24, 2011
A long-term Norwegian study reveals the number of people who experience acid reflux at least once a week has gone up by nearly 50% in the last 10 years, with women appearing to be more susceptible to the condition than men... Read More
HPV Vaccine Does Not Alter Sexual Behavior
Dec 24, 2011
According to a national study by The Centers for Disease Control & Prevention published in the American Journal of Preventive Medicine, contrary to some people's belief, young women receiving recommended vaccinations for the prevention of human papillomavirus (HPV) infection and related cancers do not engage in more sexually risky behavior. Nicole C. Liddon, Ph.D... Read More
Anti-Growth Factor Drugs Show Potential For Reducing Malignant Ascites In Advanced Ovarian Cancer Patients
Dec 23, 2011
According to a novel phase II randomized study published Online First in The Lancet Oncology, a new anti-VEGF drug aflibercept that obstructs the action of vascular endothelial growth factor (VEGF) can prevent malignant ascites (excessive fluid in the abdomen that contains cancer cells), a prevalent and painful complication of advanced ovarian cancer from developing... Read More
Presentations Highlight Results Of Clinical Data For MLN8237 And VELCADE® In The Treatment Of Lymphoma
Dec 23, 2011
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) reported the presentation of results from a phase 2 trial evaluating MLN8237, an investigational inhibitor of Aurora A kinase, in patients with aggressive B-cell and T-cell non-Hodgkin lymphoma (NHL)... Read More
Previous Page Next Page